Netherlands Archives

News and Trends 27 Aug 2015

Dutch Startup receives €2.5M from Europe to Block Cancer’s Spreading

The Eurostars program supports the Dutch start-up Oncodrone with fresh money to bring its metastasis-blocking drug towards clinical trials. Even with a promising technology, it’s not easy to succeed in the biotech field. The Eurostars program helps small companies through the tough starting phase. This year, the 2013 founded biotech start-up Oncodrone gets a 2.5 […]

August 27, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 26 Aug 2015

It’s proven: The (Almost) Universal Flu Vaccine is Possible!

The foundation stone was laid: A Dutch-American collaboration published in Science the first proof of concept that we could replace the seasonal flu shots with a vaccine that recognizes almost every subtype. The influenza virus is incredibly variable. A yearly refreshment of flu shots is necessary to provide a moderate protection against it, and subtypes […]

August 26, 2015 - 3 minutesmins - By Philip Hemme

News and Trends 12 Aug 2015

A Tale of Love for UniQure and Bristol-Myers Squibb

In May, Bristol-Myers Squibb (BMS) nailed down the exclusive access to uniQure’s gene therapy platform to treat cardiovascular diseases. Everything seems to work out fine as BMS paid $53M (€47M) for three new targets and additional shares to own nearly 10% of the company. UniQure is a Dutch pioneer in the field of gene therapy. It […]

August 12, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 6 Jul 2015

Kiadis launches its Cell-based Immunotherapies on European stock markets

Kiadis Pharma has launched an IPO on Euronext Amsterdam and Euronext Brussels with the aim of raising €32.7M. The company will invest the money in two cell-based immunotherapies for blood cancer and inherited blood disorders. Kiadis has filed for an Initial Public Offering on the Dutch and Belgian exchange markets. The money raised on the […]

July 6, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Jun 2015

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Each year, BIO Philadelphia awards the Everyday Superheroes of Biotech Industry. Here’s the story of Bernard Muller, co-founder of Treeway, a Dutch biotech company focused on the treatment of Amyotrophic lateral sclerosis (ALS). Bernard Muller is an extraordinary person, being himself a ALS patient and an entrepreneur who started his own Biotech company. Last week, we were talking […]

June 22, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 3 Jun 2015

Avantium’s bioplastic, latest Green Hope for the Agribusiness?

After many awards and famous collaborations, the Dutch biotech company Avantium signed a deal with Tereos for the production of its 100% biobased plastic. The Bioplastic provider is moving forward to disrupt an established market! Initially created as a spin off of Shell, Avantium is a 15 years old Dutch company specialized in the area of advanced […]

June 3, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 27 May 2015

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

Qiagen has launched its Qiagen Clinical Insight bioinformatics content and software platform. The software aims at clinical testing labs that perform next generation sequencing. The platform allows interpreting and reporting on genomic variants identified in the sequencing assays. The Clinical Insight platform is a potent tool that evaluates genomic variants comparing them with published biomedical […]

May 27, 2015 - 1 minutemin - By Lourdes Riquelme

News and Trends 22 May 2015

arGEN-X’ Antibody Platform struck a new Dermatology alliance

arGEN-X and LEO Pharma allied to develop innovative antibody-based solutions for the treatment of chronic inflammation underlying many skin conditions. The deal amounts to a total of €104.5M, from which arGEN-X will receive €4.5M as an upfront payment and up to €100M in royalties. LEO Pharma will receive exclusive access to an already existing arGEN-X antibody […]

May 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 8 May 2015

MorphoSys acquired Lanthio, a Dutch Peptide Therapeutic company

MorphoSys has acquired the Dutch biopharmaceutical company Lanthio Pharma. Morphosys already held 19.98% of Lanthio Pharma and will now pay €20M to purchase all outstanding shares. Thanks to the transaction MorphoSys can add Lanthio Pharma’s lead compound, LP2, to its growing proprietary portfolio. The compound, a novel lanthipeptide in development for diabetic nephropathy and fibrotic […]

May 8, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 22 Apr 2015

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

Kineta and researchers from the University of Groningen, Netherlands, announced new data from a study that showed dalazatide (formerly ShK-186) is effective in immunomodulating the cells causing inflammation and damage of small blood vessels in various organs in samples from patients with Granulomatosis with Polyangiitis (GPA). The data were presented at the 17th International ANCA […]

April 22, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 7 Apr 2015

A New Key Strategic Collaboration Between BMS and UniQure

Last month, Bristol-Myers Squibb (BMS) and UniQure, the Dutch pioneer in human gene therapy, were at the forefront of the scene after having agreed on two collaborations, respectively, an agreement between Bavarian Nordic & BMS and a collaboration between Sympromics & UniQure. A few days ago, they announced an exclusive strategic collaboration to develop gene therapies for cardiovascular […]

April 7, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 5 Mar 2015

Synpromics and UniQure, new Collaboration in Gene Therapy.

Synpromics has formed a collaboration with uniQure, the Dutch pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene therapies to liver. Synpromics, a leading synthetic biology company, will use its unique approach to develop synthetic promoters with upregulated, liver cell specific, activity whilst also decreasing the promoter molecular […]

March 5, 2015 - 2 minutesmins - By Lourdes Riquelme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Netherlands

Dutch Startup receives €2.5M from Europe to Block Cancer’s Spreading

It’s proven: The (Almost) Universal Flu Vaccine is Possible!

A Tale of Love for UniQure and Bristol-Myers Squibb

Kiadis launches its Cell-based Immunotherapies on European stock markets

A Dutch entrepreneur curing his ALS disease became BIO’s Superhero

Avantium’s bioplastic, latest Green Hope for the Agribusiness?

Qiagen offers a powerful bioinformatics tool for Next-gen sequencing

arGEN-X’ Antibody Platform struck a new Dermatology alliance

MorphoSys acquired Lanthio, a Dutch Peptide Therapeutic company

Synthetic sea anemone’s peptide to cure Autoimmune Diseases

A New Key Strategic Collaboration Between BMS and UniQure

Synpromics and UniQure, new Collaboration in Gene Therapy.

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!